Bard PowerPort Lawsuit – Fracture, Migration and Infection Claims in MDL 3081

Bard PowerPort lawsuit claims are moving toward trial in one of the largest medical device dockets in the country. Thousands of patients say their implanted port catheter fractured, migrated, or caused a serious bloodstream infection. These devices are placed in cancer patients and others who need long-term IV access. When a port fails, the consequences can be severe. This guide explains the litigation, who may qualify, and what to expect in 2026 and beyond.

What Is the Bard PowerPort Lawsuit About?

A PowerPort is an implanted vascular access device. Surgeons place a small reservoir under the skin, usually in the chest. A thin catheter runs from that reservoir into a large vein. Patients receiving chemotherapy, antibiotics, or dialysis rely on these ports for months or years. The devices are made by C.R. Bard, a subsidiary of Becton, Dickinson and Company. Bard and Becton Dickinson are the primary defendants in the litigation.

The core allegation involves the catheter tubing itself. Plaintiffs claim the polyurethane material, marketed as Chronoflex, contains excessive barium sulfate. Barium sulfate makes the catheter visible on imaging. However, plaintiffs allege the particles separate from the tubing over time. That process is said to leave microfractures and pits on the catheter surface. As a result, the catheter allegedly becomes brittle and prone to cracking inside the body.

Reported injuries fall into three broad groups. Fracture claims involve catheter fragments breaking off. Migration claims involve those fragments traveling through the bloodstream toward the heart or lungs. Infection claims involve bacteria colonizing the degraded surface, leading to sepsis or endocarditis. Blood clots and cardiac arrhythmia are also alleged. Many patients need emergency retrieval surgery. A Bard PowerPort lawsuit typically seeks damages for these revision procedures and related harm.

Importantly, Bard has not recalled the devices over the barium sulfate issue. The FDA issued a Class 2 recall in 2020 covering certain PowerPort models for other reasons. That action did not address the fracture allegations now at the center of the litigation. Adverse event reports continue to appear in the FDA MAUDE database.

MDL Case Status and Key Facts

The Judicial Panel on Multidistrict Litigation created MDL 3081 on August 8, 2023. Consolidation lets one judge manage shared discovery and pretrial rulings. Each case remains individual, though. An MDL is not a class action.

The docket has grown quickly. There were roughly 1,973 pending cases in October 2025. That figure rose to about 3,564 by July 2026. In February 2024, the panel confirmed the MDL covers port reservoir infection claims, not just catheter defect claims. As a result, the eligible injury pool expanded considerably.

The first bellwether trial concluded in May 2026. The jury returned a defense verdict on failure-to-warn claims. However, jurors deadlocked on the design defect question. That case involved an infection injury. Observers generally view infection claims as harder to prove than fracture claims. The August 2026 trial will test a fracture case for the first time. Its outcome may shape settlement talks significantly. Current filings and orders are posted on the District of Arizona website.

Who Qualifies for the Bard PowerPort Lawsuit?

Eligibility starts with device identification. You generally need proof that a Bard PowerPort, PowerPort ClearVUE, or similar Bard implanted port was used. Operative reports and implant stickers usually confirm this. Without product identification, a claim is difficult to pursue. For example, a patient who only recalls “a chemo port” may need hospital records to establish the manufacturer.

Qualifying injuries typically include catheter fracture, catheter migration or embolization, and serious bloodstream infection. Deep vein thrombosis, pulmonary embolism, endocarditis, cardiac arrhythmia, and sepsis are also commonly alleged. In most cases, the injury must have required medical intervention. Surgical removal or revision of the port is strong supporting evidence. Wrongful death claims may be brought by eligible family members.

Timing matters as well. Most claims involve devices implanted from roughly 2000 forward, when the relevant catheter materials were in use. Each Bard PowerPort lawsuit is also governed by a state statute of limitations. Those deadlines typically run two to four years from injury or discovery. Discovery rules vary widely by state. Only a licensed attorney can confirm which deadline applies to your situation.

How to File a Bard PowerPort Lawsuit Claim

Start by collecting records. Request your implant operative report, imaging studies, hospital discharge summaries, and removal records. Photographs of retrieved fragments help when available. Billing records can document out-of-pocket costs. Gather these before your first consultation if possible.

Next, consult a licensed product liability attorney experienced in MDL practice. Most work on contingency, meaning no upfront fee. The attorney will screen your device identification and injury type. If the case qualifies, counsel can typically direct-file into the District of Arizona. Direct filing avoids transfer delays from your home district.

After filing, the court requires a Plaintiff Fact Sheet. This detailed questionnaire covers medical history, implant details, treating providers, and claimed damages. Deadlines are strict. Judge Campbell has dismissed cases for fact sheet noncompliance. Product identification documentation must also be produced. Typically, your legal team handles collection of records on your behalf. Filing a Bard PowerPort lawsuit is a multi-month process, so early preparation helps.

Settlement Updates and What to Expect

No global settlement exists as of July 2026. Bard has not announced a settlement program or matrix. The split verdict in the first bellwether reduced immediate settlement pressure on the defense. However, that trial addressed only infection claims. Fracture and migration claims remain untested before a jury.

The August 18, 2026 fracture trial is the key event to watch. Three more trials follow through February 2027. Historically, defendants in device MDLs open serious negotiations after several bellwether results. As a result, meaningful settlement discussions may not occur until 2027 at the earliest. Any timeline remains uncertain.

Compensation in any Bard PowerPort lawsuit varies considerably. Courts and settlement programs typically weigh injury severity, number of revision surgeries, permanent damage, medical expenses, lost income, and age. Fragment migration to the heart generally ranks higher than a localized infection. Nobody can promise a specific figure. Be cautious of any advertisement suggesting guaranteed compensation. You may qualify for damages, but only an attorney reviewing your records can assess value.

State-by-State Considerations

State law still governs the substance of each claim in an MDL. The transferee judge applies the law of the plaintiff’s home state. Tort reform therefore changes outcomes case by case. Texas caps exemplary damages under Chapter 41 of the Civil Practice and Remedies Code. Florida’s 2023 reforms shortened many negligence deadlines to two years. Michigan and New Jersey apply strong FDA-compliance defenses in product cases.

Filing volume is heaviest in states with large cancer treatment populations. Arizona, California, Texas, Florida, Pennsylvania, and New York account for a substantial share of claims. Arizona also serves as the MDL venue. For state-specific deadlines, see our guides for Texas, California, Florida, and New York. General statute of limitations background is available through Cornell Legal Information Institute.

Frequently Asked Questions

Has the Bard PowerPort been recalled?

Not for the fracture allegations at issue in the litigation. The FDA issued a Class 2 recall in 2020 covering certain models for unrelated reasons. Devices remain on the market today.

Is a Bard PowerPort lawsuit a class action?

No. MDL 3081 is multidistrict litigation, not a class action. Each case keeps its own facts, damages, and potential outcome. Cases may return to home courts for trial if not resolved.

How long will my case take?

Timelines vary widely. Bellwether trials run through February 2027, and no global settlement exists yet. In most cases, plaintiffs should expect a process measured in years, not months. Consult a licensed attorney about your specific circumstances.

Check If You May Qualify

Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.

Official Sources & Resources

For verified mass tort and MDL information:

• JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
• DOJ: justice.gov — settlement announcements and press releases
• FDA: fda.gov — drug recalls, warning letters, and safety alerts
• CDC: cdc.gov — health condition data and exposure guidelines
• EPA: epa.gov — environmental contamination data
• Cornell LII: law.cornell.edu — plain-English legal definitions

Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

Related Guides

• All Active MDL Cases
• More in This Category
• Tort Reform by State — 50-State Comparison
• All 50 State Tort Reform Guides
• Mass Tort Explainers
• Demographic Guides
• Mass Tort Tips
• Texas Tort Reform Guide
• New York Tort Reform Guide
• Pennsylvania Tort Reform Guide

Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.